GRASSI, GUIDO
 Distribuzione geografica
Continente #
NA - Nord America 86.625
AS - Asia 55.878
EU - Europa 35.355
SA - Sud America 7.982
AF - Africa 1.284
OC - Oceania 150
Continente sconosciuto - Info sul continente non disponibili 73
Totale 187.347
Nazione #
US - Stati Uniti d'America 84.618
SG - Singapore 20.650
CN - Cina 10.925
VN - Vietnam 8.490
HK - Hong Kong 8.232
RU - Federazione Russa 6.722
SE - Svezia 6.066
BR - Brasile 6.017
IT - Italia 4.479
DE - Germania 4.347
IE - Irlanda 3.806
UA - Ucraina 2.745
GB - Regno Unito 1.812
FR - Francia 1.775
IN - India 1.412
CA - Canada 1.300
FI - Finlandia 1.042
KR - Corea 892
BD - Bangladesh 805
AR - Argentina 719
TR - Turchia 676
ID - Indonesia 626
IQ - Iraq 557
AT - Austria 506
MX - Messico 429
PK - Pakistan 398
ZA - Sudafrica 397
NL - Olanda 380
JP - Giappone 322
EC - Ecuador 314
ES - Italia 304
PL - Polonia 291
SA - Arabia Saudita 289
PH - Filippine 268
CO - Colombia 242
VE - Venezuela 212
DK - Danimarca 193
UZ - Uzbekistan 188
MA - Marocco 134
CL - Cile 133
PY - Paraguay 131
MY - Malesia 130
AU - Australia 123
TN - Tunisia 123
EG - Egitto 121
KE - Kenya 120
BE - Belgio 118
CZ - Repubblica Ceca 99
AE - Emirati Arabi Uniti 96
TW - Taiwan 89
PE - Perù 87
JO - Giordania 86
ET - Etiopia 79
TH - Thailandia 74
IR - Iran 72
NP - Nepal 69
PT - Portogallo 69
RO - Romania 66
KZ - Kazakistan 64
LT - Lituania 62
AZ - Azerbaigian 59
UY - Uruguay 59
GR - Grecia 58
DZ - Algeria 57
CH - Svizzera 56
LB - Libano 54
BO - Bolivia 51
EU - Europa 50
JM - Giamaica 49
PS - Palestinian Territory 49
AL - Albania 46
BG - Bulgaria 45
NG - Nigeria 44
DO - Repubblica Dominicana 42
OM - Oman 42
IL - Israele 41
SN - Senegal 40
HU - Ungheria 34
KG - Kirghizistan 32
PA - Panama 31
BY - Bielorussia 28
RS - Serbia 28
BH - Bahrain 27
TT - Trinidad e Tobago 27
CR - Costa Rica 25
HN - Honduras 24
NO - Norvegia 23
SK - Slovacchia (Repubblica Slovacca) 23
SY - Repubblica araba siriana 22
LK - Sri Lanka 21
LV - Lettonia 21
NZ - Nuova Zelanda 21
BA - Bosnia-Erzegovina 20
EE - Estonia 20
MU - Mauritius 20
CI - Costa d'Avorio 19
GE - Georgia 19
LY - Libia 19
KH - Cambogia 17
AM - Armenia 16
Totale 186.970
Città #
Ann Arbor 12.308
Singapore 10.797
Hong Kong 8.105
Ashburn 6.637
Fairfield 6.265
Woodbridge 6.104
Houston 4.622
San Jose 4.314
Dublin 3.628
Chandler 3.317
Wilmington 2.889
Jacksonville 2.846
Seattle 2.614
Ho Chi Minh City 2.534
Frankfurt am Main 2.486
New York 2.249
Dearborn 2.032
Hanoi 2.025
Cambridge 2.011
Stockholm 1.960
Dallas 1.733
Chicago 1.709
Hefei 1.654
Princeton 1.646
Beijing 1.470
The Dalles 1.402
Santa Clara 1.348
Milan 1.280
Los Angeles 1.159
Lauterbourg 904
Seoul 833
Lawrence 778
Moscow 725
Altamura 723
Nanjing 704
São Paulo 511
Buffalo 505
Shanghai 501
Lachine 460
Hangzhou 452
San Diego 431
Helsinki 397
Vienna 377
Jakarta 347
Guangzhou 334
Council Bluffs 332
Da Nang 331
Toronto 312
Orem 299
Boardman 286
Haiphong 281
Andover 277
Munich 277
Nanchang 242
London 240
Baghdad 239
Tokyo 215
Shenyang 210
Hebei 191
Salt Lake City 190
Changsha 189
Dong Ket 189
Rio de Janeiro 187
Rome 183
Ottawa 181
Tianjin 178
Warsaw 178
Nuremberg 165
Istanbul 160
Tashkent 160
Johannesburg 153
Chennai 152
Atlanta 144
Jiaxing 143
Jinan 140
Brooklyn 138
Falls Church 136
Biên Hòa 131
Hải Dương 128
Norwalk 125
Dhaka 123
Montreal 123
Brasília 119
Can Tho 116
Denver 115
Lahore 115
Belo Horizonte 114
Lissone 112
Mumbai 112
Phoenix 112
Amsterdam 108
Fremont 108
Quận Bình Thạnh 107
Columbus 106
Quito 106
Ninh Bình 105
Zhengzhou 105
Elk Grove Village 101
Ha Long 100
San Francisco 98
Totale 121.413
Nome #
Behaviour of regional adrenergic outflow in mild-to-moderate renal failure 2.050
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) 847
Echocardiographic Phenotypes of Subclinical Organ Damage: Clinical and Prognostic Value in the General Population. Findings from the Pamela Study 598
2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension 535
'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: Morphological criteria and clinical impact 528
Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis 526
Sex-related relationships between uric acid and target organ damage in hypertension 479
Predictors of pwv progression over a three years follow up: focus on psychological characteristics 477
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 467
Myocardial Mechanics in Acromegaly: A Meta-Analysis of Echocardiographic Studies 458
Baroreceptors as a target of device-based neuromodulation in heart failure: Long-term outcomes 454
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology? 447
Contrasting effects of carotid baroreceptor stimulation on regional sympathetic drive in chronic human heart failure 441
Big data, observational research and P-value: a recipe for false-positive findings? A study of simulated and real prospective cohorts 436
Heart rate as a sympathetic marker during acute adrenergic challenge 423
Sympathetic Overactivation in the Resistant Hypertensive Phenotype: A Meta-Analysis of Published Studies 411
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 403
Comparison of echotracking and magnetic resonance assessment of abdominal aorta distensibility and relationships with pulse wave velocity 388
Persistence of arterial functional abnormalities after successful coronary revascularization 382
Early alterations in left ventricular diastolic function in normotensive diabetic patients 382
Does the 9p region affect arterial stiffness? Results from a cohort of hypertensive individuals 378
Hemodynamic effects of acute and prolonged administration of nitrendipine in essential hypertension 369
The effects of sex and method of blood pressure measurement on genetic associations with blood pressure in the PAMELA study 365
In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers 365
Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects 361
Calcium antagonists and neural control of circulation in essential hypertension 357
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 357
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 352
A case of Pseudomonas Aeruginosa commercial tattoo infection 351
Differing associations for sport versus occupational physical activity and cardiovascular risk 351
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 348
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 345
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified 343
Cardiovascular Remodeling after Endovascular Treatment for Thoracic Aortic Injury 337
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. 336
Psychological Predictors of Arterial Stiffness Progression over a Three Years Follow Up 334
Statins and the risk of diabetes: Evidence from a large population-based cohort study 329
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 323
Cardiopulmonary reflex before and after regression of left ventricular hypertrophy in essential hypertension 322
Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies 322
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 321
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 320
Effect of angiotensin converting enzyme inhibition on cardiovascular regulation during reflex sympathetic activation in sodium-replete patients with essential hypertension 316
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 315
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 313
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 312
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 311
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period. 311
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 309
Cardiopulmonary receptor regulation of renin release 309
Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis 307
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 305
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 304
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 304
The Pamela study: main findings and perspectives 301
Heart rate as cardiovascular risk factor 299
Exploring the interplay between job strain and different domains of physical activity on the incidence of coronary heart disease in adult men 298
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 298
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 298
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 297
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach 296
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 295
Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation 294
Regional differences in sympathetic activation in lean and obese normotensive individuals with obstructive sleep apnoea 294
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 294
Prognostic significance of masked tachycardia in hypertension: Evidence from a prospective international registry 293
Pulse wave velocity progressione over a 3.7 years follow-up: focus on metabolic syndrome. 293
Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies 292
Neurogenic abnormalities in masked hypertension 291
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 291
2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC) 290
Patterns of regional sympathetic nerve traffic in preascitic and ascitic cirrhosis 290
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 289
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 289
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 288
Comparison between non-invasive and invasive pulse wave velocity assessment in human beings 288
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 287
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 285
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 285
Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients 284
Modification of arterial baroreflexes by captopril in essential hypertension 284
Prevalence of cardiovascular risk factors in an unselected Italian population. Results of the CardioLab Project 2004-2008 282
Excessive sympathetic activation in heart failure with obesity and metabolic syndrome: Characteristics and mechanisms 282
It is never too late for a genetic disease: a case of a 79-year-old man with persistent hypokalemia 282
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites 282
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 281
Body fat mass is a strong and negative predictor of peak stimulated growth hormone and bone mineral density in healthy adolescents during transition period 279
The Big Data Era in Cardiology and Cardiovascular Medicine: Advanced Analytics for Truly Personalized Care 278
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome 278
Effects of ageing on the cardiopulmonary receptor reflex in normotensive humans 277
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 277
Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: A meta-analysis 276
Historical Archive of Blood Pressure and Evolution of Hypertension 276
Baroreflex and non-baroreflex modulation of vagal cardiac control after myocardial infarction 275
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: Results of a double-blind randomized multicentre trial 274
Structural alterations of the retinal microcirculation in the "prehypertensive" high-normal blood pressure state 274
Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension 274
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes 274
Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium 274
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 273
Totale 35.585
Categoria #
all - tutte 631.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 631.638


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.979 0 0 0 0 0 0 0 0 0 0 784 1.195
2021/202210.935 791 951 1.293 930 814 744 526 679 638 762 978 1.829
2022/202314.314 2.112 4.076 1.131 1.153 862 2.360 194 817 889 109 400 211
2023/202411.472 322 293 482 532 1.772 2.742 2.129 325 1.204 226 212 1.233
2024/202531.683 1.760 3.941 1.278 1.366 2.575 926 1.539 1.204 3.523 4.124 3.456 5.991
2025/202668.008 8.086 5.966 5.890 7.638 7.574 3.917 9.810 3.526 5.925 8.153 1.523 0
Totale 190.944